Edna Chow-Maneval
4PUBLICATIONS
69CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Nov 06, 2025
Enozertinib Is a Selective, Brain-Penetrant EGFR Inhibitor for Treating Non-Small Cell Lung Cancers with EGFR Exon 20 and Atypical Mutations.Melissa R Junttila, Claire E Repellin, Sumeet Salaniwal
|Aug 23, 2024
ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors.Christopher T Chen, Vishesh Khanna, Shivaani Kummar
|Jan 16, 2024
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide.Wassim Abida, Andrew W Hahn, Neal Shore
|Nov 26, 2019
Entrectinib in Two Pediatric Patients With Inflammatory Myofibroblastic Tumors Harboring ROS1 or ALK Gene Fusions.Srikanth R Ambati, Emily K Slotkin, Edna Chow-Maneval
Pageof 1
Frequent Collaborators
3 joint publications
Pratik S Multani
3 joint publications
Anneleen Daemen
3 joint publications
Melissa R Junttila
2 joint publications
Shravani R Barkund
2 joint publications
Alexander I Spira
2 joint publications
Aleksandr Pankov
2 joint publications
Jian Wang
2 joint publications
Rongda Xu
2 joint publications
Rupal Patel
2 joint publications
Maureen Duff
